Mariem Galuia, Joseph Gabriel Mchayleh, Lampros Karakozis, Michael Abdelmasseh, George Nassif, Mark Soliman, Matthew Albert, Justin Kelly, Mohamedtaki Abdulaziz Tejani, Ahmed Zakari. "Minimal residual disease (MRD) assessment by circulating tumor DNA (ctDNA) to stratify recurrence risk and adjuvant treatment benefit in a real-world colorectal cancer (CRC) cohort.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3616